MineshPMehtaMDFASTRO

Central Nervous System Cancer, Thoracic Cancer

Professor and Chair, Radiation Oncology, School of Medicine, Florida International University

Overview of Dr. Mehta

Dr. Minesh Mehta is a radiation oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami and South Miami Hospital. He received his medical degree from University of Zambia, School of Med and has been in practice 36 years. Dr. Mehta accepts several types of health insurance, listed below. He is one of 24 doctors at Baptist Hospital of Miami and one of 10 doctors at South Miami Hospital who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Office
8900 N Kendall Dr
# Miami
Miami, FL 33176
Book by Phone+1(786) 738-9219

Fax+1 305-279-7778

Education & Training

University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1984 - 1988
University of Zambia, School of MedClass of 1981

Certifications & Licensure

CA State Medical License 2011 - 2026
FL State Medical License 2015 - 2026
OH State Medical License 2010 - 2026
MD State Medical License 2012 - 2025
WI State Medical License 1987 - 2025
IL State Medical License 1985 - 2017
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2010, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2013
Top Doctors:Baltimore Area Castle Connolly, 2012

Clinical Trials

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Start of enrollment: 1999 Feb 02
Completed
Phase 2
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma Start of enrollment: 1998 Oct 01
Completed
Phase 2, Phase 3
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
Terminated
Phase 3
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Terminated
Phase 2
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Start of enrollment: 2006 Jan 01
Completed
Phase 3
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2010 Jul 01
Completed
Phase 2
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2011 Mar 01
Completed
Phase 2
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2014 Oct 27
Active, not recruiting
Phase 2
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). Start of enrollment: 2016 Jul 01
Active, not recruiting
Phase 3
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia Start of enrollment: 2020 Aug 28
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
Benjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, Raymond Y Huang, Javier E Villanueva-Meyer
AJNR. American Journal of Neuroradiology. 2024-12-09
Radiotherapeutic advances in the management of glioblastoma.
Omer Gal, Minesh P Mehta, Rupesh Kotecha
Journal of Neuro-Oncology. 2024-12-01
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.
Connor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, Paul D Brown, David M DeStephano
Neuro-Oncology. 2024-10-03

Journal Articles

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
Mark R Gilbert, Kevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Terri S Armstrong, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, David G Brachman, Merid..., Neurosurgery
Multi-Institutional External Validation of a Novel Glioblastoma Prognostic Nomogram Incorporating MGMT Methylation
Shahed N Badiyan, Minesh P Mehta, Yuan James Rao, Liam T Kane, Jason K Molitoris, Jiayi Huang, Journal of Neuro-Oncology

Press Mentions

How Miami Cancer Institute's World-Class Radiation Therapy Team Is Changing LivesOctober 3rd, 2024
Miami Cancer Institute Hosts Particle Beam Radiotherapy Experts from Across the GlobeJuly 15th, 2022
Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment SurvivalJune 2nd, 2022
Join now to see all

Grant Support

Nabtc (Ucsf Project Leader) U Of WisconsinNational Cancer Institute1998–2008
Phase II Trial Of EMD 121974 For Recurrent GlioblastomaNational Center For Research Resources2007
Phase II Study Of Xrt + Low-Dose Temozolomide Followed By Temozolomide + CPT-11National Center For Research Resources2006–2007
Phase I/II Study Of OSI-774 And CCI-779 In Recurrent Malignant GliomaNational Center For Research Resources2006–2007
Phase I/II Trial Of CPT-11 And Temozolomide In Recurrent Malignant GliomaNational Center For Research Resources2004–2006
Phase I/II Trial Of R115777 In Patients With Recurrent Malignant GliomaNational Center For Research Resources2004–2005
Improving Cancer Outcome--Adaptive Helical TomotherapyNational Cancer Institute2001–2005
Phase I/II ZD1839 In Astrocytoma Or Glioblastoma And MeningiomaNational Center For Research Resources2004
Phase I/II OSI-774 In Recurrent Malignant Gliomas And Malignant Gliomas Post XrtNational Center For Research Resources2004
Phase I Study Of Zd 1839 And Temozolomide For The Treatment Of GliomasNational Center For Research Resources2004
Tomotherapy Based On Functional MRINational Cancer Institute2001–2002
Tomotherapy Based Dose PER Fraction Escalation In NsclcNational Cancer Institute2001–2002
Phase II Trial Of Thymidine &Carboplatin For Recurrent Malignant GLINational Center For Research Resources1999–2002
Phase Ib/Ii Trial Of PC 0120as Radiosensitizer In Metastatic Brain CancerNational Center For Research Resources1998–2002
Trial Of Irinotecan In PTS W Recurrent Malignant GliomaNational Center For Research Resources2000
Gadolinium Texaphyrin (Pci-0120) Radiation Sensitizer In Whole Brain Radiation THNational Center For Research Resources2000
Therapeutic Studies Of Primary CNS MalignanciesNational Cancer Institute1994–1997

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment